Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant (IMROZ)

Trial Overview

Am I Eligible?

Participating US Centers

MD Anderson Cancer Center
The University of Texas

This center is currently accepting patients.

Houston, TX


Sarah Cannon
TriStar Centennial Medical Center

This center is currently accepting patients.

Nashville, TN


Texas Oncology

This center is currently accepting patients.

Tyler, TX


Florida Cancer Specialists
North

This center is currently accepting patients.

St. Petersburg, FL


HCA Midwest Health

This center is currently accepting patients.

Kansas City, MO


Saint Vincent Healthcare

This center is currently accepting patients.

Billings, MT


Tennessee Oncology
Memorial Plaza

This center is currently accepting patients.

Chattanooga, TN


Florida Cancer Specialists

This center is currently accepting patients.

Fort Myers, FL

ACCEPTING

This trial is currently open and accepting patients.



Additional Information
Trial Phase

Phase 3

Trial Enrollment

440 sparks required

Trial Sponsors
  • Sanofi
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;